Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Transplant Proc ; 54(6): 1597-1600, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35868873

RESUMO

BACKGROUND: DNA damage and oncogenic viruses increase the risk of cancer post-kidney transplantation, including skin cancer, Kaposi's sarcoma, oral cancer, and non-Hodgkin lymphoma. Here we report an uncommon case of liver angiosarcoma that occurred 8 years after kidney transplantation. This study strictly complied with the Helsinki Congress and the Istanbul Declaration regarding donor source. CASE REPORT: A 57-year-old female patient received a cadaver kidney transplantation 8 years ago. She followed a long-term regimen of tacrolimus, mycophenolate sodium, and everolimus, with good renal function. She received annual regular abdominal ultrasound examinations after kidney transplantation, which showed no findings. The patient suffered from several symptoms for approximately 2 weeks before a scheduled abdominal ultrasound: diarrhea, epigastric pain, abdominal fullness, tea-colored urine, and little stool passage. The abdominal computerized tomography showed multiple hepatic tumors in both the hepatic lobes with engorged vasculatures and mild hemoperitoneum. A liver biopsy revealed the histopathology of angiosarcoma. The patient suffered multiple organ failure within one month of treatment. CONCLUSIONS: Various post-transplant malignancies are not uncommon after transplantation, warranting periodic screenings for any symptoms in these patients.


Assuntos
Hemangiossarcoma , Transplante de Rim , Neoplasias Hepáticas , Everolimo , Feminino , Hemangiossarcoma/etiologia , Humanos , Imunossupressores , Transplante de Rim/efeitos adversos , Neoplasias Hepáticas/etiologia , Neoplasias Hepáticas/cirurgia , Pessoa de Meia-Idade , Ácido Micofenólico , Tacrolimo , Chá
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA